This investigation was designed to determine the extent to which changes in serum
lipid values in treated patients, and the absence of such changes in untreated patients,
correlate with changes in the quantity of calcified plaque determined by electron
beam tomography in asymptomatic patients without clinical coronary artery disease
(CAD).
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to American Journal of CardiologyAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Relation of coronary artery calcium identified by electron beam tomography to serum lipoprotein levels and implications for treatment.Am J Cardiol. 2001; 87: 406-412
- Electron beam tomography and National Cholesterol Education Program guidelines in asymptomatic women.J Am Coll Cardiol. 2001; 37: 1506-1511
- Quantification of coronary artery calcium using ultrafast computed tomography.J Am Coll Cardiol. 1990; 15: 827-833
- Coronary artery disease.Radiology. 1998; 208: 807-810
- Identification of patients at increased risk of first unheralded acute myocardial infarction by electron beam computed tomography.Circulation. 2000; 101: 850-855
Lipid Research Clinics Manual of Laboratory Operations. Lipid and lipoprotein analysis. vol I. HEW publication no. NIH 75–628. Washington, DC: US Government Printing Office; 1974
- Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III).JAMA. 2001; 285: 2486-2497
- Rates of progression of coronary calcium by electron beam tomography.Am J Cardiol. 2000; 86: 8-11
- Influence of lipid-lowering therapy on the progression of coronary artery calcififcation. A prospective evaluation.Circulation. 2002; 106: 1077-1082
- Effect of HMG-CoA reductase inhibitors on coronary artery disease as assessed by electron-beam computed tomography.N Engl J Med. 1998; 339: 1972-1978
Article info
Publication history
Accepted:
January 21,
2003
Received in revised form:
January 21,
2003
Received:
November 25,
2002
Identification
Copyright
© 2003 Excerpta Medica Inc. Published by Elsevier Inc. All rights reserved.
